**Meet the editors**

Leticia B. A. Rangel, Pharm.D., Ph.D., is an Associate Professor of the Department of Pharmaceutical Sciences, a member of the Biotechnology/RENORBIO and of the Biochemistry and Pharmacology Programs at the Federal University of Espirito Santo (UFES). As the head of the Laboratory of Cellular and Molecular Biology of Human Cancer, she coordinates projects on ovarian and

breast cancers, with emphasis on the cellular and molecular basis of the diseases, and mechanisms involved in the chemoresistant phenotype of cancer cells. Her scientific network includes universities in Brazil and in the United States of America, as well as the private sector. She has been awarded by the Brazilian government in recognition to her contribution in cancer research.

Ian Victor Silva, Pharm.D., Ph.D., is an Associate Professor at the Department of Morphology, a member of the Biotechnology/RENORBIO Program at the Federal University of Espirito Santo (UFES). As the head of Aging Cell Laboratory, he coordinates projects on aging associated diseases, with emphasis on the molecular mechanisms of these illnesses. His scientific network includes universities in Brazil as well United States of America. Along with his fruitful collaboration within the academic sector, Dr. Silva also works as a consultant for the private sector, mostly as a scientific advisor for clinical trials and pharmaceutical private sector management. He has been recognized by the Brazilian government, as well as internationally, for his contribution to research on aging.
